We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZURA icon
551
Zura Bio
ZURA
$497M
$16.4M 0.03%
2,750,000
SILA
552
DELISTED
Sila Realty Trust
SILA
$16.4M 0.03%
690,860
-80,711
-10% -$1.98M
WTFC icon
553
Wintrust Financial
WTFC
$10.7B
$16.3M 0.03%
117,200
+13,000
+12% +$1.88M
RHP icon
554
Ryman Hospitality Properties
RHP
$8.4B
$16.3M 0.03%
176,312
+101,312
+135% +$9.72M
TSN icon
555
Tyson Foods
TSN
$20.2B
$16.1M 0.02%
251,655
-3,900
-2% -$242K
WST icon
556
West Pharmaceutical
WST
$23.1B
$16.1M 0.02%
64,207
-700
-1% -$174K
HCAC
557
Hall Chadwick Acquisition Corp
HCAC
$294M
$16.1M 0.02%
+1,620,000
New +$16.2M
L icon
558
Loews
L
$24.3B
$16.1M 0.02%
150,700
+7,700
+5% +$824K
VRSK icon
559
Verisk Analytics
VRSK
$26.4B
$16M 0.02%
84,400
-26,400
-24% -$5.36M
EL icon
560
Estee Lauder
EL
$29B
$15.8M 0.02%
220,584
+78,600
+55% +$8.03M
DG icon
561
Dollar General
DG
$25.9B
$15.7M 0.02%
132,200
-26,500
-17% -$3.78M
WDAY icon
562
Workday
WDAY
$33.4B
$15.7M 0.02%
120,800
-30,100
-20% -$4.78M
BSX icon
563
PUT
Boston Scientific
BSX
$65.8B
$15.7M 0.02%
+250,000
New +$20M
DNMX
564
Dynamix Corp III
DNMX
$15.6M 0.02%
1,575,000
NTRS icon
565
Northern Trust
NTRS
$22.2B
$15.6M 0.02%
111,900
-13,800
-11% -$1.99M
VHCP
566
Vine Hill Capital Investment Corp II
VHCP
$307M
$15.6M 0.02%
+1,575,000
New +$15.6M
MTSI icon
567
MACOM Technology Solutions
MTSI
$20.4B
$15.6M 0.02%
70,057
-132,443
-65% -$29.6M
MUZE
568
Muzero Acquisition Corp
MUZE
$272M
$15.5M 0.02%
+1,575,000
New +$15.5M
KRSP
569
Rice Acquisition Corporation 3
KRSP
$481M
$15.5M 0.02%
1,500,000
BG icon
570
Bunge Global
BG
$23.6B
$15.4M 0.02%
120,800
-1,400
-1% -$163K
CMC icon
571
Commercial Metals
CMC
$7.63B
$15.4M 0.02%
+250,000
New +$18.1M
JAN
572
Janus Living Inc
JAN
$6.67B
$15.3M 0.02%
+650,000
New +$15.2M
CSGP icon
573
CoStar Group
CSGP
$11.3B
$15.3M 0.02%
378,100
-4,500
-1% -$234K
HII icon
574
Huntington Ingalls Industries
HII
$11.3B
$15.2M 0.02%
40,007
-6,622
-14% -$2.73M
IPFXU
575
Inflection Point Acquisition Corp VI Units
IPFXU
$15.2M 0.02%
+1,500,000
New +$15.2M

Similar funds

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.